Torrent Pharmaceuticals share news and announcements
NSE: TORNTPHARMBSE: 500420Pharmaceuticals & BiotechnologyLarge Cap
Last close ₹4,524.40down ₹90.90 (1.97%)BSE ₹4,482.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹4,615.30.
52-week range of traded prices to 23 Oct 2026
₹3,532.60Low, 6 Nov 2025₹5,250.00High, 3 Aug 2026
- Next results date: the board meets on 23 Oct 2026 to consider: other business matters and financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,72,094 Cr61st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 30 Jul 2026
- 78.9
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.84%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 30 Jul 2026
- 27.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 30 Jul 2026
- 11.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.84
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,28,59557.1% delivered
Torrent Pharmaceuticals share news and announcements
864 announcements, routine notices left out, newest first. Page 3 of 18.
Jul 2025
28 Jul · Board meeting
21 Jul · Analysts
7 Jul · General Updates
Jun 2025
30 Jun · Analysts
29 Jun · Board meeting
May 2025
20 May · Corporate action
20 May · Board meeting
20 May · Updates
13 May · Analysts
Apr 2025
Mar 2025
19 Mar · Rating
Feb 2025
21 Feb · Analysts
14 Feb · Analysts
8 Feb · Analysts
7 Feb · Analysts
Jan 2025
24 Jan · Updates
24 Jan · Results
15 Jan · Analysts
13 Jan · Corporate action
Dec 2024
19 Dec · Updates
Nov 2024
Oct 2024
25 Oct · Board meeting
24 Oct · Rating